Intracellular pharmacodynamics of antibiotics

Goodman & Gilman's The Pharmacological Basis of Therapeutics

Brunton, L. L. (1985) · Cited by 7,321

Goodman and Gilman's the Pharmacological Basis of Therapeutics

Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,796

Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents.

Ohkuma, S., & Poole, B. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.7.3327 · Cited by 2,173

Lysosomotropic Agents

De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901

Role of nitric oxide synthesis in macrophage antimicrobial activity

Nathan, C. F., & Hibbs, J. B. (1991) · Current Opinion in Immunology · doi:10.1016/0952-7915(91)90079-g · Cited by 1,523

Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine.

Tipper, D. J., & Strominger, J. L. (1965) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.54.4.1133 · Cited by 1,008

Tularemia

Ellis, J., Oyston, P. C. F., Green, M., & Titball, R. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.631-646.2002 · Cited by 814

Mammalian defensins in immunity: more than just microbicidal

Yang, D., Biragyn, A., Kwak, L. W., & Oppenheim, J. J. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02246-9 · Cited by 696

Murine Salmonellosis Studied by Confocal Microscopy: Salmonella typhimurium Resides Intracellularly Inside Macrophages and Exerts a Cytotoxic Effect on Phagocytes In Vivo

Richter-Dahlfors, A., Buchan, A. M. J., & Finlay, B. B. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.4.569 · Cited by 502

The cell biology of Listeria monocytogenes infection

Portnoy, D. A., Auerbuch, V., & Glomski, I. J. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200205009 · Cited by 448

Pharmacokinetics and Pharmacodynamics of Antibacterial Agents

Levison, M. E., & Levison, J. H. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.06.008 · Cited by 564

Nanotechnology approaches for global infectious diseases

Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520

The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions

Gan, B., Gaynord, J. S., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 524

Quinolones in 2005: an update

Françoise Van Bambeke, A., Michot, J.-M., Eldere, J. V., & Tulkens, P. M. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01131.x · Cited by 342

Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?

Thwaites, G. E., & Gant, V. A. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2508 · Cited by 319

Delivery of antibiotics with polymeric particles

Xiong, M., Bao, Y., Yang, X., Zhu, Y., & Wang, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.002 · Cited by 304

The Concept of an Ideal Antibiotic: Implications for Drug Design

Gajdács, M. (2019) · Molecules · doi:10.3390/molecules24050892 · Cited by 275

Pharmacodynamic Evaluation of the Intracellular Activities of Antibiotics against Staphylococcus aureus in a Model of THP-1 Macrophages

Barcia-Macay, M., Seral, C., Mingeot‐Leclercq, M., Tulkens, P. M., & Françoise Van Bambeke, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.841-851.2006 · Cited by 266

Reducing Bacterial Infections and Biofilm Formation Using Nanoparticles and Nanostructured Antibacterial Surfaces

Mi, G., Shi, D., Wang, M., & Webster, T. J. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800103 · Cited by 249

Delivery systems to increase the selectivity of antibiotics in phagocytic cells

Briones, E., Colino, C. I., & Lanao, J. M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.027 · Cited by 226

Bacteria-Targeting Nanoparticles with Microenvironment-Responsive Antibiotic Release To Eliminate Intracellular Staphylococcus aureus and Associated Infection

Yang, S., Han, X., Yang, Y., Qiao, H., Yu, Z., Liu, Y., Wang, J., & Tang, T. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b15678 · Cited by 214

Correcting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility Testing

Ersoy, S. C., Heithoff, D. M., Barnes, L., V, Tripp, G. K., House, J. K., Marth, J. D., Smith, J. W., & Mahan, M. J. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.05.026 · Cited by 213

Effective Antibiotics against ‘Candidatus Liberibacter asiaticus’ in HLB-Affected Citrus Plants Identified via the Graft-Based Evaluation

Zhang, M., Guo, Y., Powell, C. A., Doud, M. S., Yang, C., & Duan, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111032 · Cited by 165

Dual Targeting of Intracellular Pathogenic Bacteria with a Cleavable Conjugate of Kanamycin and an Antibacterial Cell-Penetrating Peptide

Brezden, A., Mohamed, M. F., Nepal, M., Harwood, J. S., Kuriakose, J., Seleem, M. N., & Chmielewski, J. A. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b04831 · Cited by 160

Importance of Relating Efficacy Measures to Unbound Drug Concentrations for Anti-Infective Agents

González, D., Schmidt, S., & Derendorf, H. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00092-12 · Cited by 151

Molecular Vehicles for Mitochondrial Chemical Biology and Drug Delivery

Jean, S. R., Tulumello, D. V., Wisnovsky, S., Lei, E. K., Pereira, M. P., & Kelley, S. O. (2014) · ACS Chemical Biology · doi:10.1021/cb400821p · Cited by 150

Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives.

Françoise Van Bambeke, A., Barcia-Macay, M., Lemaire, S., & Tulkens, P. M. (2006) · PubMed · Cited by 138

Confocal light absorption and scattering spectroscopic microscopy monitors organelles in live cells with no exogenous labels

Itzkan, I., Qiu, L., Fang, H., Zaman, M. M., Vitkin, E. I., Ghiran, I. C., Salahuddin, S., Modell, M. D., Andersson, C., Kimerer, L. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708669104 · Cited by 131

Exosome-encapsulated antibiotic against intracellular infections of methicillin-resistant Staphylococcus aureus

Yang, X., Shi, G., Guo, J. J., Wang, C., & He, Y. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s179380 · Cited by 128

Staphylococcus aureus develops increased resistance to antibiotics by forming dynamic small colony variants during chronic osteomyelitis

Tuchscherr, L. P. N., Kreis, C., Hoerr, V., Flint, L., Hachmeister, M., Geraci, J., Bremer-Streck, S., Kiehntopf, M., Medina, E., Kribus, M., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv371 · Cited by 129

Can intracellular Staphylococcus aureus in osteomyelitis be treated using current antibiotics? A systematic review and narrative synthesis

Zelmer, A. R., Nelson, R., Richter, K., & Atkins, G. J. (2022) · Bone Research · doi:10.1038/s41413-022-00227-8 · Cited by 124

Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections

Baudoux, P., Bles, N., Lemaire, S., Mingeot-Leclercq, M. P., Tulkens, P. M., & Françoise Van Bambeke, A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl489 · Cited by 108

Eradicating intracellular MRSA via targeted delivery of lysostaphin and vancomycin with mannose-modified exosomes

Yang, X., Xie, B., Peng, H., Shi, G., Banne, S., Guo, J. J., Wang, C., & He, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.045 · Cited by 107

Combination Antibiotic Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections

van Hal, S. J., Tong, S. Y. C., & Davis, J. S. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1396906 · Cited by 106

Antimicrobial Activity against Intraosteoblastic Staphylococcus aureus

Valour, F., Trouillet‐Assant, S., Riffard, N., Tasse, J., Flammier, S., Rasigade, J., Chidiac, C., Vandenesch, F., Ferry, T., & Laurent, F. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04359-14 · Cited by 101

Influence of Efflux Transporters on the Accumulation and Efflux of Four Quinolones (Ciprofloxacin, Levofloxacin, Garenoxacin, and Moxifloxacin) in J774 Macrophages

Michot, J.-M., Seral, C., Françoise Van Bambeke, A., Mingeot‐Leclercq, M., & Tulkens, P. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2429-2437.2005 · Cited by 97

Drug delivery approaches to overcome bacterial resistance to β-lactam antibiotics

Abeylath, S. C., & Turos, E. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.9.931 · Cited by 93

Repurposing clinically approved cephalosporins for tuberculosis therapy

Ramón‐García, S., del Río, R. G., Santos-Villarejo, Á., Sweet, G., Cunningham, F., Barros, D., Ballell, L., Mendoza-Losana, A., Ferrer, S. B., & Thompson, C. J. (2016) · Scientific Reports · doi:10.1038/srep34293 · Cited by 86

An efficient system for intracellular delivery of beta-lactam antibiotics to overcome bacterial resistance

Abed, N., Hassane, F. S., Zouhiri, F., Mougin, J., Nicolas, V., Desmaële, D., Gref, R., & Couvreur, P. (2015) · Scientific Reports · doi:10.1038/srep13500 · Cited by 91

Riboflavin along with antibiotics balances reactive oxygen species and inflammatory cytokines and controls Staphylococcus aureus infection by boosting murine macrophage function and regulates inflammation

Dey, S., & Bishayi, B. (2016) · Journal of Inflammation · doi:10.1186/s12950-016-0145-0 · Cited by 85

Intracellular Activity of Antibiotics against Staphylococcus aureus in a Mouse Peritonitis Model

Sandberg, A., Hessler, J. H. R., Skov, R. L., Blom, J., & Møller, J. K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01605-07 · Cited by 83

Intracellular proliferation of S. aureus in osteoblasts and effects of rifampicin and gentamicin on S. aureus intracellular proliferation and survival

Mohamed, W. A., Sommer, U., Sethi, S., Domann, E., Thormann, U., Schutz, I., Lips, K., Chakraborty, T., Schnettler, R., & Alt, V. (2014) · European Cells and Materials · doi:10.22203/ecm.v028a18 · Cited by 84

Liposomal antibiotics for the treatment of infectious diseases

Alhariri, M., Azghani, A. O., & Omri, A. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.822860 · Cited by 85

Nanoparticle based Drug Delivery Systems for Treatment of Infectious Diseases

Salouti, M., & Ahangari, A. (2014) · InTech eBooks · doi:10.5772/58423 · Cited by 78

Smart Drug Delivery System

Sezer, A. D. (2016) · InTech eBooks · doi:10.5772/60475 · Cited by 78

Bacterium-Derived Cell-Penetrating Peptides Deliver Gentamicin To Kill Intracellular Pathogens

Gomarasca, M., Martins, T. F. C., Greune, L., Hardwidge, P. R., Schmidt, M. A., & Rüter, C. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02545-16 · Cited by 76

Novel bioactive hydrophobic gentamicin carriers for the treatment of intracellular bacterial infections

Imbuluzqueta, E., Elizondo, E., Gamazo, C., Moreno‐Calvo, E., Veciana, J., Ventosa, N., & Blanco‐Prieto, M. J. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.11.031 · Cited by 75

Targeting Intracellular Pathogenic Bacteria with Unnatural Proline‐Rich Peptides: Coupling Antibacterial Activity with Macrophage Penetration

Kuriakose, J., Hernandez‐Gordillo, V., Nepal, M., Brezden, A., Pozzi, V., Seleem, M. N., & Chmielewski, J. A. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302693 · Cited by 75

Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections

Su, F., Srinivasan, S., Lee, B., Chen, J., Convertine, A. J., West, T. E., Ratner, D. M., Skerrett, S. J., & Stayton, P. S. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.014 · Cited by 69

Host-dependent Induction of Transient Antibiotic Resistance: A Prelude to Treatment Failure

Kubicek-Sutherland, J. Z., Heithoff, D. M., Ersoy, S. C., Shimp, W. R., House, J. K., Marth, J. D., Smith, J. W., & Mahan, M. J. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.08.012 · Cited by 72

Polymer-augmented liposomes enhancing antibiotic delivery against intracellular infections

Su, F., Chen, J., Son, H., Kelly, A. M., Convertine, A. J., West, T. E., Skerrett, S. J., Ratner, D. M., & Stayton, P. S. (2018) · Biomaterials Science · doi:10.1039/c8bm00282g · Cited by 66

Chasing bacteria within the cells using levofloxacin-loaded hyaluronic acid nanohydrogels

Montanari, E., D’Arrigo, G., Meo, C. D., Virga, A., Coviello, T., Passariello, C., & Matricardi, P. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.03.003 · Cited by 60

Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines

Lemaire, S., Françoise Van Bambeke, A., Appelbaum, P. C., & Tulkens, P. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp267 · Cited by 60

Activity of three β-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus

Lemaire, S., Françoise Van Bambeke, A., Mingeot‐Leclercq, M., & Tulkens, P. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki094 · Cited by 59

Hydrophobic modification improves the delivery of cell-penetrating peptides to eliminate intracellular pathogens in animals

Tang, Q., Tan, P., Dai, Z., Wang, T., Xu, S., Ding, Y., Jin, J., Zhang, X., Zhang, Y., Zhou, C., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.11.055 · Cited by 58

Poly(lactic-co-glycolic) Acid–Lipid Hybrid Microparticles Enhance the Intracellular Uptake and Antibacterial Activity of Rifampicin

Maghrebi, S., Joyce, P., Jambhrunkar, M., Thomas, N., & Prestidge, C. A. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b22991 · Cited by 56

A Phage Lysin Fused to a Cell-Penetrating Peptide Kills Intracellular Methicillin-Resistant Staphylococcus aureus in Keratinocytes and Has Potential as a Treatment for Skin Infections in Mice

Wang, Z., Kong, L., Liu, Y., Fu, Q., Cui, Z., Wang, J., Ma, J., Wang, H., Yan, Y., & Sun, J. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.00380-18 · Cited by 57

Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, againstStaphylococcus aureus,Listeria monocytogenes, andLegionella pneumophilain Human THP-1 Macrophages

Lemaire, S., Françoise Van Bambeke, A., & Tulkens, P. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00203-09 · Cited by 55

Toward an Optimized Treatment of Intracellular Bacterial Infections: Input of Nanoparticulate Drug Delivery Systems

Ladavière, C., & Gref, R. (2015) · Nanomedicine · doi:10.2217/nnm.15.128 · Cited by 55

Pharmacodynamic Evaluation of the Intracellular Activity of Antibiotics towards Pseudomonas aeruginosa PAO1 in a Model of THP-1 Human Monocytes

Buyck, J. M., Tulkens, P. M., & Françoise Van Bambeke, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02609-12 · Cited by 52

Cellular Pharmacodynamics of the Novel Biaryloxazolidinone Radezolid: Studies with Infected Phagocytic and Nonphagocytic cells, UsingStaphylococcus aureus,Staphylococcus epidermidis,Listeria monocytogenes, andLegionella pneumophila

Lemaire, S., Kosowska-Shick, K., Appelbaum, P. C., Verween, G., Tulkens, P. M., & Françoise Van Bambeke, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01724-09 · Cited by 51

A “Double-Edged” Scaffold: Antitumor Power within the Antibacterial Quinolone

Bisacchi, G. S., & Hale, M. R. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666151223095839 · Cited by 51

Antibacterial Activity of Ciprofloxacin-Encapsulated Cockle Shells Calcium Carbonate (Aragonite) Nanoparticles and Its Biocompatability in Macrophage J774A.1

Isa, T., Zakaria, Z., Rukayadi, Y., Noor, M. H. M., Jaji, A. Z., Imam, M. U., Hammadi, N. I., & Mahmood, S. K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050713 · Cited by 50

Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo

Wang, X., Wang, X., Teng, D., Mao, R., Hao, Y., Wang, J., Li, Z., & Wang, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22245-5 · Cited by 49

The bactericidal effects of anti-MRSA agents with rifampicin and sulfamethoxazole-trimethoprim against intracellular phagocytized MRSA

Yamaoka, T. (2007) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-007-0521-z · Cited by 48

Bacteria in the respiratory tract—how to treat? Or do not treat?

Prat, C., & Lacoma, A. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.09.005 · Cited by 51

In vitro antimicrobial activity against 10 North American and European Lawsonia intracellularis isolates

Wattanaphansak, S., Singer, R. S., & Gebhart, C. J. (2008) · Veterinary Microbiology · doi:10.1016/j.vetmic.2008.08.007 · Cited by 47

Antimicrobial Activities of Daptomycin, Vancomycin, and Oxacillin in Human Monocytes and of Daptomycin in Combination with Gentamicin and/or Rifampin in Human Monocytes and in Broth against Staphylococcus aureus

Baltch, A. L., Ritz, W. J., Bopp, L. H., Michelsen, P. B., & Smith, R. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00973-06 · Cited by 46

Chemical Biology Approach to Reveal the Importance of Precise Subcellular Targeting for Intracellular Staphylococcus aureus Eradication

Bai, S., Song, J., Pu, H., Yu, Y., Song, W.-W., Chen, Z., Wang, M., Campbell‐Valois, F., Wong, W., Cai, Q., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c09587 · Cited by 45

Comparison of the In Vitro Efficacies of Moxifloxacin and Amoxicillin against Listeria monocytogenes

Grayo, S., Join‐Lambert, O., Desroches, M.-C., & Monnier, A. L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01211-07 · Cited by 42

Beyond oncology — Application of HPMA copolymers in non-cancerous diseases☆

Liu, X.-M., Miller, S. C., & Wang, D. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.006 · Cited by 41

Ketolides: pharmacological profile and rational positioning in the treatment of respiratory tract infections

Françoise Van Bambeke, A., Harms, J. M., Laethem, Y. V., & Tulkens, P. M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.2.267 · Cited by 41

Cell-Penetrating Antimicrobial Peptides – Prospectives for Targeting Intracellular Infections

Bahnsen, J. S., Franzyk, H., Sayers, E. J., Jones, A. T., & Nielsen, H. M. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1550-9 · Cited by 40

Nanomaterials for Delivering Antibiotics in the Therapy of Pneumonia

Tang, J., Ouyang, Q., Li, Y., Zhang, P., Jin, W., Qu, S., Yang, F., He, Z., & Qin, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415738 · Cited by 39

Killing of Staphylococcus aureus in murine macrophages by chloroquine used alone and in combination with ciprofloxacin or azithromycin

Bishayi, B., & Dey, S. (2015) · Journal of Inflammation Research · doi:10.2147/jir.s76045 · Cited by 38

Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications

Pea, F. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0572-y · Cited by 40

Garlic-Derived Exosome-like Nanovesicles-Based Wound Dressing for Staphylococcus aureus Infection Visualization and Treatment

Zhou, S., Huang, P., Cao, Y., Hua, X., Yao, Y., & Liu, S. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c01256 · Cited by 36

A bioinspired hierarchical nanoplatform targeting and responding to intracellular pathogens to eradicate parasitic infections

Yu, Y., Li, J., Zhang, Y., Ma, Z., Sun, H., Wei, X., Bai, Y., Wu, Z., & Zhang, X. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121309 · Cited by 36

Interaction of amoxicillin with DNA in human lymphocytes and H. pylori-infected and non-infected gastric mucosa cells

Arabski, M., Kaźmierczak, P., Wiśniewska‐Jarosińska, M., Popławski, T., Klupińska, G., Chojnacki, J., Drzewoski, J., & Błasiak, J. (2005) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.01.004 · Cited by 36

Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin

Imbuluzqueta, E., Lemaire, S., Gamazo, C., Elizondo, E., Ventosa, N., Veciana, J., Françoise Van Bambeke, A., & Blanco‐Prieto, M. J. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks172 · Cited by 36

Hyaluronan‐Based Nanohydrogels for Targeting Intracellular S. Aureus in Human Keratinocytes

Montanari, E., Oates, A., Meo, C. D., Meade, J. L., Cerrone, R., Francioso, A., DeVine, D., Coviello, T., Mancini, P., Mosca, L., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701483 · Cited by 36

The Interplay between Daptomycin and the Immune System

Kelesidis, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00052 · Cited by 35

Targeted Drug Delivery Systems for Eliminating Intracellular Bacteria

Feng, W., Chittò, M., Moriarty, T. F., Li, G., & Wang, X. (2022) · Macromolecular Bioscience · doi:10.1002/mabi.202200311 · Cited by 37

Factors influencing the intracellular activity of fluoroquinolones: a study using levofloxacin in a Staphylococcus aureus THP-1 monocyte model

Nguyen, H. A., Grellet, J., Paillard, D., Dubois, V., Quentin, C., & Saux, M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl079 · Cited by 33

Genome of Ca. Pandoraea novymonadis, an Endosymbiotic Bacterium of the Trypanosomatid Novymonas esmeraldas

Kostygov, A. Y., Butenko, A., Nenarokova, A., Tashyreva, D., Flegontov, P., Lukeš, J., & Yurchenko, V. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01940 · Cited by 32

Antibiotic persistence of intracellular Brucella abortus

Mode, S., Ketterer, M., Québatte, M., & Dehio, C. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010635 · Cited by 33

Liposome Encapsulation of Ciprofloxacin Improves Protection against Highly Virulent Francisella tularensis Strain Schu S4

Hamblin, K. A., Armstrong, S. J., Barnes, K. B., Davies, C. H., Wong, J. P., Blanchard, J. D., Harding, S. V., Simpson, A. J. H., & Atkins, H. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02555-13 · Cited by 32

Efficacy of Liposome-Encapsulated Ciprofloxacin in a Murine Model of Q Fever

Norville, I. H., Hatch, G. J., Bewley, K. R., Atkinson, D., Hamblin, K. A., Blanchard, J. D., Armstrong, S. J., Pitman, J. K., Rayner, E. L., Hall, G. A., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03443-14 · Cited by 31

Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis

Fors, J., Strydom, N., Fox, W. S., Keizer, R. J., & Savić, R. M. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008107 · Cited by 30

Delayed parasite elimination in human infections treated with clindamycin parallels ‘delayed death’ of Plasmodium falciparum in vitro

Burkhardt, D., Wiesner, J., Stoesser, N. E., Ramharter, M., Uhlemann, A., Issifou, S., Jomaa, H., Krishna, S., Kremsner, P. G., & Borrmann, S. (2006) · International Journal for Parasitology · doi:10.1016/j.ijpara.2006.12.010 · Cited by 29

Macromolecular Nanotherapeutics and Antibiotic Adjuvants to Tackle Bacterial and Fungal Infections

Dey, R. K., Mukherjee, S., Barman, S., & Haldar, J. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202100182 · Cited by 28

Microfluidic arenas for war games between neutrophils and microbes

Ellett, F. E., Jalali, F., Marand, A. L., Jorgensen, J. A., Mutlu, B. R., Lee, J., Raff, A. B., & Irimia, D. (2019) · Lab on a Chip · doi:10.1039/c8lc01263f · Cited by 27

Antibiotic Drug Delivery Systems for the Intracellular Targeting of Bacterial Pathogens

Chifiriuc, M. C., Holban, A. M., Curuțiu, C., Diţu, L.-M., Mihăescu, G., Oprea, A. E., Grumezescu, A. M., & Lazăr, V. (2016) · InTech eBooks · doi:10.5772/61327 · Cited by 26

Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters

Cavanaugh, J. S., Jou, R., Wu, M.-H., Dalton, T. L., Kurbatova, E. V., Ershova, J. V., Cegielski, J. P., & for the Global PETTS Investigators (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx022 · Cited by 27

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial

Thwaites, G. E., Auckland, C., Barlow, G. D., Cunningham, R., Davies, G., Edgeworth, J. D., Greig, J. M., Hopkins, S., Jeyaratnam, D., Jenkins, N., et al. (2012) · Trials · doi:10.1186/1745-6215-13-241 · Cited by 26

Principles of use of antibacterial agents

Hessen, M. T., & Kaye, D. (2004) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2004.04.002 · Cited by 26

The immune response and antibacterial therapy

Anuforom, O., Wallace, G. R., & Piddock, L. J. V. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0355-0 · Cited by 26

Targeting intracellular bacteria with an extended cationic amphiphilic polyproline helix

Nepal, M., Thangamani, S., Seleem, M. N., & Chmielewski, J. A. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00227c · Cited by 25

Predicting in vivo phospholipidosis-inducing potential of drugs by a combined high content screening and in silico modelling approach

Bauch, C., Bevan, S. J., Woodhouse, H. J., Dilworth, C., & Walker, P. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.01.014 · Cited by 24

High-Throughput Intracellular Antimicrobial Susceptibility Testing of Legionella pneumophila

Chiaraviglio, L., & Kirby, J. E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01248-15 · Cited by 24

Novel Intracellular Antibiotic Delivery System Against Staphylococcus Aureus : Cloxacillin-Loaded Poly( D , L -Lactide-Co-Glycolide) Acid Nanoparticles

Lacoma, A., Usón, L., Mendoza, G., Sebastián, V., García-García, E., Muriel-Moreno, B., Domínguez, J., Arruebo, M., & Prat, C. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0371 · Cited by 24

Ginsenoside 20(S)-Rh2 promotes cellular pharmacokinetics and intracellular antibacterial activity of levofloxacin against Staphylococcus aureus through drug efflux inhibition and subcellular stabilization

Chen, X., Qian, F., Wang, Y., Liu, Y., Sun, Y., Zha, W., Hao, K., Zhou, F., Wang, G., & Zhang, J. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00751-z · Cited by 24

Treatment of Citrobacter kosen Infection with Ciprofloxacin and Cefotaxime in a Preterm Infant

McPherson, C. C., Gal, P., & Ransom, J. L. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l008 · Cited by 24

Dual-targeted poly(amino acid) nanoparticles deliver drug combinations on-site: an intracellular synergistic strategy to eliminate intracellular bacteria

Zhao, D., Feng, W., Kang, X., Li, H., Liu, F., Zheng, W., Li, G., & Wang, X. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb00125c · Cited by 23

Macrophages Targeted Drug Delivery as a Key Therapy in Infectious Disease

Cătoi, C. (2014) · Cited by 23

Matryoshka-Type Gastro-Resistant Microparticles for The Oral Treatment of Mycobacterium Tuberculosis

Andreu, V., Larrea, A., Rodríguez-Fernández, P., Alfaro, S., Gracia, B., Lucía, A., Usón, L., Gómez, A.-C., Mendoza, G., Lacoma, A., et al. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0258 · Cited by 24

In vitroantibiotic activity against intraosteoblasticStaphylococcus aureus: a narrative review of the literature

Marro, F. C., Abad, L., Blocker, A., Laurent, F. J., Josse, J., & Valour, F. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab301 · Cited by 23

Susceptibility to Alternative Oral Antimicrobial Agents in Relation to Sequence Type ST131 Status and Coresistance Phenotype among Recent Escherichia coli Isolates from U.S. Veterans

Johnson, J. R., Drawz, S. M., Porter, S. B., & Kuskowski, M. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00650-13 · Cited by 22

Delivery of host cell-directed therapeutics for intracellular pathogen clearance

Collier, M. A., Gallovic, M. D., Peine, K. J., Duong, A. D., Bachelder, E. M., Gunn, J. S., Schlesinger, L. S., & Ainslie, K. M. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.845524 · Cited by 22

Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea—challenges and opportunities

Theuretzbacher, U., Barbee, L. A., Connolly, K. L., Drusano, G. L., Fernandes, P., Hook, E. W., Jerse, A. E., O’Donnell, J. P., Unemo, M., Françoise Van Bambeke, A., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.08.006 · Cited by 21

Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives.

Françoise Van Bambeke, A., Barcia-Macay, M., Lemaire, S., & Tulkens, P. M. (2006) · PubMed · Cited by 138

Research progress of intracellular activity of antibiotics and its celluar pharmacokinetics evaluation

Wang, G. (2012) · Zhongguo linchuang yaolixue yu zhiliaoxue

[Intracellular pharmacokinetics and pharmacodynamics of antibiotics].

Tulkens, P. M. (1996) · PubMed · Cited by 2

Challenges to Antibiotic Activity in Tissue

Barza, M. J. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.5.910 · Cited by 45

AUC Area under the concentration-time curve

Françoise Van Bambeke, A., Barcia-Macay, M., Lemaire, R., Paul, M., Pharmacologie, U., Moléculaire, C., & Concentration, P. P. (2014)